JAK 1/2 Blockade in MDA5 Gain-of-Function

J Clin Immunol. 2018 Nov;38(8):844-846. doi: 10.1007/s10875-018-0563-2. Epub 2018 Nov 15.

Kirsty E McLellan¹, Neil Martin², Joyce E Davidson¹, Nuno Cordeiro³, Bridget D Oates⁴, Bénédicte Neven^{5

6

7}, Gillian I Rice⁸, Yanick J Crow^{9

10}

¹ Paediatric Rheumatology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G514TF, UK.
² Paediatric Rheumatology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G514TF, UK. [email protected].
³ Rainbow House Child Development Centre, Ayrshire General Hospital, Kilwinning Road, Irvine, KA128SS, UK.
⁴ Paediatrics, University Hospital Crosshouse, Kilmarnock, East Ayrshire, UK.
⁵ Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
⁶ Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France.
⁷ INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Paris, France.
⁸ Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
⁹ Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, UK. [email protected].
¹⁰ Laboratory of Neurogenetics and Neuroinflammation, Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France. [email protected].

No abstract available

Publication types